Skip to main content
Article thumbnail
Location of Repository

The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects

By Suzana Almoosawi, Lorna Fyfe, Clement Ho and Emad A S Al-Dujaili


Numerous studies indicate that polyphenol-rich chocolate reduces fasting blood glucose, blood pressure (BP) and total cholesterol in healthy individuals and hypertensives with or without glucose intolerance. The aim of the present study was to investigate the effect of two doses of polyphenol-rich dark chocolate (DC) on fasting capillary whole blood glucose, total cholesterol and BP and to examine whether improvements in these parameters are associated with changes in adrenocorticoid excretion in overweight and obese individuals. The study used a randomised, single-blind, cross-over design where fourteen overweight and obese subjects were randomised to either take 20 g DC with 500 mg polyphenols then 20 g DC with 1000 mg polyphenols or vice-versa. Participants followed each diet for 2 weeks separated by a 1-week washout period. It was observed that the 500 mg polyphenol dose was equally effective in reducing fasting blood glucose levels, systolic BP (SBP) and diastolic BP (DBP) as the 1000 mg polyphenol dose suggesting that a saturation effect might occur with increasing dose of polyphenols. There was also a trend towards a reduction in urinary free cortisone levels with both groups although it did not reach statistical significance. No changes in anthropometrical measurements were seen. We suggest that more research is required to investigate the mechanism(s) by which polyphenol-rich foods influence health

Publisher: Cambridge University Press
OAI identifier:

Suggested articles


  1. (1983). A method to assess energy expenditure in children and adults.
  2. (2002). A Photographic Atlas of Food Portion Sizes. London: Food standard agency publications.
  3. (2000). Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. doi
  4. (2008). Acute dark chocolate and cocoa ingestion and endothelium function: a randomised controlled crossover trial.
  5. (2005). Anthropometric indices and the incidence of hypertension: a comparative analysis. doi
  6. (2007). Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. doi
  7. (2007). Associations of serum minerals with body mass index in adult women. doi
  8. (2008). Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate.
  9. (2006). Body mass index and waist circumference both contribute to differences in insulinmediated glucose disposal in nondiabetic adults.
  10. (2002). Chemical composition and flavor of Ecuadorian cocoa liquor. doi
  11. (2001). Chlorogenic acid and caffeic acid are absorbed in humans.
  12. (1997). Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose-6-phophatase. doi
  13. (1997). Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. doi
  14. (2003). Chlorogenic acid, quercetin-3-rutinoside and black tea polyphenols are extensively metabolised in humans.
  15. (2003). Chocolate and blood pressure in elderly individuals with isolated hypertension. doi
  16. (2006). Chocolate and prevention of cardiovascular disease: a systematic review.
  17. (2003). Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects.
  18. (2003). Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. doi
  19. (2006). Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen elderly study. doi
  20. (2005). Cocoa reduces blood pressure and Insulin resistance and improves endothelium-dependent vasodilation in hypertensive. doi
  21. (2006). Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28812 postmenopausal women. doi
  22. (2001). Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. doi
  23. (2001). Consumption of high doses of chlorogenic acid present in coffee or of black tea increases plasma homocysteine concentrations in humans.
  24. (1999). Cortisol effects on body mass, blood pressure, and cholesterol in the general population. doi
  25. (2006). Cortisol secretion patterns in addiction and addiction risk. doi
  26. (2006). Development and validation of a simple and direct ELISA method for the determination of conjugated and non-conjugated testosterone excretion in urine. doi
  27. (2007). Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men. doi
  28. (2008). Dietary magnesium intake is related to metabolic syndrome in older Americans. doi
  29. (2007). Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice. doi
  30. (2005). Different polyphenolic components of soft fruits inhibit a-amylase and a-glucosidase. doi
  31. (2007). Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, Stroke, diabetes mellitus, and cancer in Panama. doi
  32. (2007). Effect f cocoa and green tea consumption on glucoregulatory biomarkers in insulin resistant men and women.
  33. (2008). Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. doi
  34. (2005). Effect of meal fat content on salivary testosterone and cortisol levels in healthy female volunteers.
  35. (2000). Effects of cocoa extracts on endothelium-dependent relaxation.
  36. (2007). Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide. doi
  37. (2003). Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. doi
  38. (2003). Glucocorticoid excess induces production in vascular endothelial cells and elicits vascular endothelial dysfunction. doi
  39. (2009). Glucocorticoid response elements and 11{beta}-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase. doi
  40. (2007). Glucocorticoids and oxidative stress. doi
  41. (1996). Grapefruit and its flavonoids inhibit 11beta-hydroxysteroid dehydrogenase. doi
  42. (2005). Hypertension, diabetes: chocolate with a single remedy?
  43. (2006). Hypertension, the Kuna, and the epidemiology of flavanols. doi
  44. (2001). Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. doi
  45. (2005). Increased cortisol bioavailability, abdominal obesity and the metabolic syndrome in obese women. doi
  46. (1998). Increased urinary free cortisol: a potential intermediate phenotype of essential hypertension. doi
  47. (1992). Inhibition of 11-beta-hydroxysteroid dehydrogenase by gossypol and bioflavonoids.
  48. (1998). Inhibition of 11beta-hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol. doi
  49. (2007). Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S adults. doi
  50. (2005). Magnesium intake, C-reactive protein and the prevalence of metabolic syndrome in middle-aged and doi
  51. (2000). Molecular mechanisms of glucocorticoid action: what is important? doi
  52. (2001). More antioxidants in cocoa.
  53. (1996). Phenolic inhibitors of a-amylase and trypsin enzymes by extracts from pears, lentils, and cocoa.
  54. (2005). Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer player. doi
  55. (2004). Relationship between procyanidin and flavor contents of cocoa liquors from different origins. doi
  56. Report of a World Health Organization (WHO) Consultation on obesity (2000) Obesity: Preventing and Managing the Global Epidemic. doi
  57. (2002). Rhabdomyolysis and arterial hypertension caused by apparent excess of mineralcorticoids: a case report.
  58. (2001). Salt loading affects cortisol metabolism in normotensive subjects: relationships with salt sensitivity. doi
  59. (2005). Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons.
  60. (2008). Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-blind, randomized, controlled trail. doi
  61. (2006). The hypothalamicpituitary–adrenal (HPA) axis in habitual smokers. doi
  62. (2006). Total polyphenol intake estimated by a modified Folin-Ciocalteu assay of urine. doi
  63. (2007). Type 2 diabetes and metabolic syndrome are associated with increased Dark chocolate and obesity 7 B r i t i s h J o u r n a l o f N u t r i t i o nexpression of 11b-hydroxysteroid dehydrogenase in obese subjects. doi
  64. (2007). Type 2 diabetes and metabolic syndrome are associated with increased Dark chocolate and obesity 7 Br iti sh Jo ur na l of N ut ri tio n expression of 11b-hydroxysteroid dehydrogenase in obese subjects.
  65. (2007). Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertension. doi
  66. (1996). Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. doi
  67. (2004). Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. doi
  68. (1999). Validity and reproducibility of a self-administered dietary questionnaire in obese and non-obese subjects.
  69. (2006). Vascular structure and function in women: relationship with body mass index.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.